| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |